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Going their own way in the NPC
T
here’s more than one way to pass through a nuclear pore, as Terry and Wente 
show. Different cargos follow different routes through the channels, suggesting a 
new mechanism for regulating import and export.
A nuclear pore is a bit like a high school hallway, with molecules and their carriers 
crowding through in both directions. As they make the crossing, carriers attach to sections of 
pore proteins (Nups) that harbor repeated stretches of phenylalanine and glycine. How binding 
to these FG repeat domains helps usher cargos through the pores remains controversial.
Three years ago, Wente’s group tested the importance of particular FG repeats by 
making yeast mutants with different combinations of the domains excised. They found that 
transport doesn’t require FG repeats in the ﬁ  laments that protrude into the cytoplasm and 
into the basket that hangs from the nuclear side.
To pin down which FG segments are essential, Terry and Wente continued the research 
with new mutants. The scientists tracked how the loss of certain domains affected mRNA 
export from the nucleus and protein import via Kapβ carriers. If the removal of an FG domain 
blocked mRNA from exiting, it didn’t necessarily prevent Kapβ cargos from entering, and vice 
versa. This difference indicates that 
the two types of cargos follow different paths through 
the pore. Cells might be able to control what goes in 
and out by altering FG domains in speciﬁ  c Nups. 
Reference: Terry, L.J., and S.R. Wente. 2007. J. Cell Biol. 
178:1121–1132.
RhoG welcomes 
leukocytes
I
nfection and injury lure leukocytes 
from the bloodstream, but they ﬁ  rst 
have to traverse a vessel wall to 
reach the traumatized tissue. As van 
Buul et al. show, the GTPase RhoG 
helps the cells make the crossing.
As leukocytes exit a blood 
vessel, they either pass right through 
the endothelial cells in the lining or 
wriggle between them. To get across 
this layer, a leukocyte ﬁ  rst hooks onto 
the protruding protein ICAM1. An endothelial cell then puckers its membrane 
to produce a cup that cradles the leukocyte. The molecular events that prompt 
cup formation remain unclear. The endothelial structures resemble the 
phagocytic cups that allow cells to gobble pathogens. Because the GTPase 
RhoG spurs phagocytosis in certain cells, van Buul et al. wanted to determine 
whether the molecule also promotes construction of endothelial cups.
The researchers found that the binding of a leukocyte to ICAM1 
activated RhoG, which congregated at the site of attachment. Knocking 
down RhoG with RNAi slashed the number of cups that cells fashioned 
and the number of leukocytes making the crossing.
An activator of RhoG, called SGEF, bound to the cytoplasmic side of 
ICAM1, suggesting that the molecule might link ICAM1 engagement to 
RhoG activation. Supporting that hypothesis, RNAi against SGEF decreased 
cup formation and hindered leukocyte crossing. Still unresolved is how the 
cups allow a leukocyte to slip through the endothelium. 
Reference: van Buul, J.D., et al. 2007. J. Cell Biol. 178:1279–1293.
Pol II piece makes 
and breaks mRNA
“C
radle to grave” describes one pro-
tein’s relationship with mRNA. As 
Lotan et al. reveal, the protein helps 
make mRNA and helps destroy it. The molecule, 
a piece of RNA polymerase II, might permit cells 
to coordinate mRNA synthesis and breakdown.
Cells degrade mRNA to eliminate damaged 
strands and manage protein synthesis. Enzymes 
fi  rst strip off the molecule’s tail of multiple ade-
nines. The demolition then sometimes proceeds 
from the 5′ to the 3′ end, usually in cytoplasmic 
structures called P-bodies. Or enzymes can chop 
up the strand in the 3′-to-5′ direction. The RNA 
polymerase II complex weaves new strands of 
mRNA, but previous work by the researchers 
sug  gested that one of its components, Rpb4p, also 
helps initiate destruction. However, Rpb4p lacks a 
site for grabbing RNA, implying that it gets help.
Lotan et al. tested whether that aid comes 
from Rpb4p’s partner, the RNA-binding protein 
Rpb7p. In yeast with a mutated rpb7 gene, 
removal of the adenine tail faltered. Moreover, 
the researchers found that Rpb7p gathered in 
P-bodies and was required for destruction of 
mRNA in the 5′-to-3′ direction. Outside P-bod-
ies, Rpb7p stimulated 3′-to-5′ mRNA break-
down, indicating that it helps orchestrate both 
mRNA demolition pathways. The next question 
to answer, the researchers say, is whether Rpb7p 
links mRNA formation in the nucleus to its 
destruction in the cytoplasm. 
Reference: Lotan, R., et al. 2007. J. Cell Biol. 
178:1133–1143.
RhoG helps an endothelial cell swaddle 
a leukocyte in membrane folds.
Removing certain FG domains disrupts 
mRNA export (top row) or protein import 
(bottom row), but not both.